Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in CRDF — Cardiff Oncology, Inc.

CIK 1167557 Greenwich, CT
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$450,256
+$343,087 QoQ
Shares Held
346,353
+423.5% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 104 holders
Holding Since
Sep 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. CRDF ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in CRDF

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $450,256 346,353
2026-03-31 $107,169 66,156
2025-09-30 $99,458 48,281
2025-06-30 $59,600 18,921
2025-03-31 $91,633 29,183
2024-12-31 $176,373 40,639
2024-09-30 $82,420 30,869
2022-06-30 $120,076 54,580
2022-03-31 $900,941 363,283
2021-12-31 $199,994 33,277
2021-09-30 $240,112 36,053